Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

ClinicalTrials.gov ID: NCT06096779

Public ClinicalTrials.gov record NCT06096779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 15, 2026, 3:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.

Study identification

NCT ID
NCT06096779
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2024
Primary completion
Jul 29, 2027
Completion
Dec 29, 2027
Last update posted
Jul 9, 2026

2024 – 2027

United States locations

U.S. sites
58
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
University of Arizona Cancer Center Tucson Arizona 85724
UC San Diego Moores Cancer Center La Jolla California 92093
University of Southern California-Keck School of Medicine -1975 Zonal Ave Los Angeles California 90089-5601
University of Southern California Newport Beach California 92663
University of California Irvine Medical Center Orange California 92868
California Liver Research Institute Pasadena California 91105-2561
University of California Davis Medical Center Sacramento California 95817
Stanford Health Care Stanford California 94305
Harbor UCLA Medical Center Torrance California 90502-2006
Cedars Sinai Comprehensive Transplant Center West Hollywood California 90048-2422
Rocky Mountain Cancer Centers (Williams) - USOR Denver Colorado 80218-1237
Hartford Healthcare Cancer Institute at Hartford Hospital Hartford Connecticut 06106
George Washington University- Medical Faculty Associates Washington D.C. District of Columbia 20037
Washington DC VA Medical Center Washington D.C. District of Columbia 20422-0001
Orlando Health Inc. Orlando Florida 32806
Northwestern University Chicago Illinois 60611-2908
University of Illinois Health Outpatient Care Center Chicago Illinois 60612-4795
The Duchossois Center for Advanced Medicine Chicago Illinois 60637-1426
University of Kentucky - Markey Cancer Center Lexington Kentucky 40536-7001
LSU Health Baton Rouge Baton Rouge Louisiana 70805
Our Lady of the Lake Cancer Institute Baton Rouge Louisiana 70808-4300
Tufts Medical Center Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Veterans Affairs Ann Arbor Healthcare System Ann Arbor Michigan 48105
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201
Henry Ford Health System Detroit Michigan 48202
Saint Luke?s Hospital of Kansas City Kansas City Missouri 64111
MorristownMedicalCenter Morristown New Jersey 07962
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901
Rutgers Cancer Institute of New Jersey at University Hospital Newark New Jersey 07103
NYU Langone Hospital - Long Island Mineola New York 11501-4064
NYU Langone Medical Center New York New York 10016-9451
Icahn School of Medicine at Mount Sinai New York New York 10029
Montefiore Medical Center The Bronx New York 10467
James J Peters Veterans Administration Medical Center - NAVREF The Bronx New York 10468-3904
Levine Cancer Institute Charlotte North Carolina 28204
Dayton VA Medical Center - NAVREF - PPDS Dayton Ohio 45428-9000
The University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104-5020
Kaiser Permanente Westside Medical Center Hillsboro Oregon 97124-5806
OHSU Knight Cancer Institute Hematology Oncology Portland Oregon 97239-3011
Jefferson Health Honickman Center Philadelphia Pennsylvania 19107
Veterans Affairs Pittsburgh Healthcare System - NAVREF - PPDS Pittsburgh Pennsylvania 15240
The West Clinic (East Campus) Germantown Tennessee 38138-1762
Nashville General Hospital at Meharry Nashville Tennessee 37208-2918
Liver Institute at Methodist Dallas Dallas Texas 75203-1260
Moody Outpatient Center ? Parkland Health Dallas Texas 75235
Texas Oncology (Worth) - USOR Dallas Texas 75246-2008
University of Texas Southwestern Medical Center Dallas Texas 75390-0001
Texas Oncology - Denison Cancer Center Denison Texas 75020-0084
Kelsey Research Foundation Houston Texas 77025-1669
Michael E Debakey VA Medical Center - NAVREF - PPDS Houston Texas 77030-4211
Houston Methodist Hospital Houston Texas 77030
Intermountain Healthcare Murray Utah 84107-5741
Intermountain Cancer Center St. George Utah 84790
Inova Schar Cancer Institute Falls Church Virginia 22042
Bon Secours St. Mary's Hospital Richmond Virginia 23226-1925
VCU Medical Center North Hospital Richmond Virginia 23298-5028
Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06096779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2026 · Synced Sep 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06096779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →